Copied from IHUB, Fletch falconer66a Re: Xena
Post# of 1460
(Total Views: 196)
Posted On: 07/09/2024 1:41:07 PM
Copied from IHUB,
Fletch
falconer66a
Re: XenaLives post# 463781
Tuesday, July 09, 2024 11:18:05 AM
Post# of 463833
No Side Effects, Just Side Benefits
...I expect patients and physicians will start discovering that there are some positive "side effects" that go beyond the targeted disease.
Yes, once blarcamesine is approved and being used in the treatment of CNS patients, a major concern will always be the "side effects" problems with CNS (and other) drugs.
I contend that blarcamesine will have no "side effects" of any consequence or significance. For blarcamesine, it will be just the opposite. The drug will display favorable "side benefits." Not only will the disease being treated be favorably addressed (the drug will work), but, at the same time, a number of "side benefits" will be obvious. One side benefit of blarcamesine will be dramatically improved sleep.
https://investorshub.advfn.com/boards/read_ms...=174724692
Fletch
falconer66a
Re: XenaLives post# 463781
Tuesday, July 09, 2024 11:18:05 AM
Post# of 463833
No Side Effects, Just Side Benefits
...I expect patients and physicians will start discovering that there are some positive "side effects" that go beyond the targeted disease.
Yes, once blarcamesine is approved and being used in the treatment of CNS patients, a major concern will always be the "side effects" problems with CNS (and other) drugs.
I contend that blarcamesine will have no "side effects" of any consequence or significance. For blarcamesine, it will be just the opposite. The drug will display favorable "side benefits." Not only will the disease being treated be favorably addressed (the drug will work), but, at the same time, a number of "side benefits" will be obvious. One side benefit of blarcamesine will be dramatically improved sleep.
https://investorshub.advfn.com/boards/read_ms...=174724692
(2)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼